Physician profile
Sarah Garber
NPI 1295362598
$855.06
in general payments reported to CMS, 2019-2025
11 companies · $530 in 2025
The $530 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $325 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450 · Education: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.07 |
| Education | $404.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $325.00 | 2024 | |
| Astellas Pharma US INC | $162.33 | 2025 | Veozah |
| Mayne Pharma Commercial LLC | $126.61 | 2025 | |
| Millicent US INC | $55.62 | 2025 | Intrarosa, Femring |
| Sage Therapeutics, LLC | $36.66 | 2025 | Zurzuvae |
| Organon LLC | $30.69 | 2025 | Nexplanon |
| Exeltis, USA INC. | $27.38 | 2025 | Slynd |
| Exact Sciences Corporation | $27.04 | 2025 | The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $24.79 | 2025 | Myfembree |
| Optumhealth Care Solutions, LLC | $23.74 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.20 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Garber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.